RGS7 anticorps
Aperçu rapide pour RGS7 anticorps (ABIN7262621)
Antigène
Voir toutes RGS7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human RGS7 (NP_002915.3).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- RGS7 (Regulator of G-Protein Signaling 7 (RGS7))
-
Autre désignation
- RGS7
-
Sujet
- RGS7 (Regulator Of G Protein Signaling 7) is a Protein Coding gene. Diseases associated with RGS7 include Prolonged Electroretinal Response Suppression and Congenital Stationary Night Blindness. Among its related pathways are Signaling by GPCR and Myometrial Relaxation and Contraction Pathways. Gene Ontology (GO) annotations related to this gene include obsolete signal transducer activity and G-protein beta-subunit binding. An important paralog of this gene is RGS6.
-
Poids moléculaire
-
Observed_MW: 58 kDa
Calculated_MW: 49 kDa/54 kDa/55 kDa/56 kDa/57 kDa
-
ID gène
- 6000
-
UniProt
- P49802
-
Pathways
- Myometrial Relaxation and Contraction, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-